BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21988191)

  • 21. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
    Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
    J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
    Baylis SA; Shah N; Minor PD
    J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.
    Saldanha J; Lelie N; Yu MW; Heath A;
    Vox Sang; 2002 Jan; 82(1):24-31. PubMed ID: 11856464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
    Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
    Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy.
    Ruppert V; Meyer T; Balbach A; Richter A; Müller HH; Maisch B; Pankuweit S;
    J Med Virol; 2011 Oct; 83(10):1818-25. PubMed ID: 21837800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA.
    Molenaar-de Backer MW; de Waal M; Sjerps MC; Koppelman MH
    Transfusion; 2016 Feb; 56(2):440-8. PubMed ID: 26354230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and analysis of a novel parvovirus B19 Genotype 3 isolate in the United States.
    Rinckel LA; Buno BR; Gierman TM; Lee DC
    Transfusion; 2009 Jul; 49(7):1488-92. PubMed ID: 19389024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The detection of parvoviruses.
    Doyle S
    Methods Mol Biol; 2011; 665():213-31. PubMed ID: 21116804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG.
    Ferguson M; Walker D; Cohen B
    Biologicals; 1997 Sep; 25(3):283-8. PubMed ID: 9324996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
    Braham S; Gandhi J; Beard S; Cohen B
    J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.
    Jia J; Ma Y; Zhao X; Huangfu C; Zhong Y; Fang C; Fan R; Lv M; Zhang J
    Virol J; 2016 Sep; 13(1):155. PubMed ID: 27639978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A collaborative study to establish the first National Standard for HIV-1 RNA nucleic acid amplification techniques (NAT) in Taiwan.
    Yang YC; Yang-Chih Shih D; Tsai MH; Cheng CH; Cheng HF; Lo CF; Wang DY
    J Virol Methods; 2013 Aug; 191(2):122-7. PubMed ID: 23608407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
    Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
    J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotypes of erythrovirus B19, their geographical distribution & circulation in cases with various clinical manifestations.
    Jain A; Kant R
    Indian J Med Res; 2018 Mar; 147(3):239-247. PubMed ID: 29923512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
    Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
    J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Report of a collaborative study to calibrate the Second International Standard for parvovirus B19 antibody.
    Ferguson M; Heath A
    Biologicals; 2004 Dec; 32(4):207-12. PubMed ID: 15572102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Look-back study on recipients of Parvovirus B19 (B19V) DNA-positive blood components.
    Juhl D; Özdemir M; Dreier J; Görg S; Hennig H
    Vox Sang; 2015 Nov; 109(4):305-11. PubMed ID: 26053938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology.
    Fryer JF; Heath AB; Minor PD;
    Biologicals; 2016 Jul; 44(4):242-251. PubMed ID: 27179913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Establishment of the first national standards for nucleic acid amplification technology assay for HBV DNA].
    Wang LN; Deng W; Shen ZY; Chen WX; Li JM
    Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):107-10. PubMed ID: 17362634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
    Hourfar MK; Schmidt M; Seifried E; Roth WK
    Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.